Literature DB >> 12655096

Heterogeneous Epstein-Barr virus latent gene expression in AIDS-associated lymphomas and in type I Burkitt's lymphoma cell lines.

R Touitou1, H Arbach1, C Cochet1, J Feuillard2, A Martin2, M Raphaël2, I Joab1.   

Abstract

Epstein-Barr virus (EBV) is associated with lymphoma in immunocompromised patients. This study provides evidence that the expression of EBV nuclear antigen-3 genes can be directed from the F promoter in different type I Burkitt's lymphoma cell lines and in some lymphomas from human immunodeficiency virus-infected patients. This expression occurs predominantly after induction of the EBV lytic cycle.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12655096     DOI： 10.1099/vir.0.18687-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  9 in total

1.  Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol).

Authors:  Hratch Arbach; Viktor Viglasky; Florence Lefeu; Jean-Marc Guinebretière; Vanessa Ramirez; Nadège Bride; Nadia Boualaga; Thomas Bauchet; Jean-Philippe Peyrat; Marie-Christine Mathieu; Samia Mourah; Marie-Pierre Podgorniak; Jean-Marie Seignerin; Kenzo Takada; Irène Joab
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation.

Authors:  Lassad Oussaief; Aurélie Hippocrate; Vanessa Ramirez; Aurore Rampanou; Wei Zhang; David Meyers; Philip Cole; Ridha Khelifa; Irène Joab
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

Review 3.  Diagnosis and management of lymphomas and other cancers in HIV-infected patients.

Authors:  Antonino Carbone; Emanuela Vaccher; Annunziata Gloghini; Liron Pantanowitz; Akin Abayomi; Paolo de Paoli; Silvia Franceschi
Journal:  Nat Rev Clin Oncol       Date:  2014-03-11       Impact factor: 66.675

4.  Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.

Authors:  Motoki Kurokawa; Subrata K Ghosh; Juan Carlos Ramos; Abdul M Mian; Ngoc L Toomey; Lisa Cabral; Denise Whitby; Glen N Barber; Dirk P Dittmer; William J Harrington
Journal:  Blood       Date:  2005-03-24       Impact factor: 22.113

Review 5.  Salubrious effects of oxytocin on social stress-induced deficits.

Authors:  Adam S Smith; Zuoxin Wang
Journal:  Horm Behav       Date:  2011-12-08       Impact factor: 3.587

6.  EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.

Authors:  Tianli Xia; Andrea O'Hara; Iguaracyra Araujo; Jose Barreto; Eny Carvalho; Jose Bahia Sapucaia; Juan Carlos Ramos; Estela Luz; Celia Pedroso; Michele Manrique; Ngoc L Toomey; Carlos Brites; Dirk P Dittmer; William J Harrington
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

Review 7.  Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer.

Authors:  Jonathan P Godbout; Ronald Glaser
Journal:  J Neuroimmune Pharmacol       Date:  2006-08-10       Impact factor: 4.147

8.  Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis.

Authors:  Masato Ikeda; Cooper K Hayes; Samantha J Schaller; Richard Longnecker
Journal:  Blood Adv       Date:  2022-07-26

Review 9.  Stress-Induced Epstein-Barr Virus Reactivation.

Authors:  Daniel G Sausen; Maimoona S Bhutta; Elisa S Gallo; Harel Dahari; Ronen Borenstein
Journal:  Biomolecules       Date:  2021-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.